arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ZIMMER BIOMET HOLDINGS, INC.

ZBH
$90.90 ▼ -3.10 (-3.30%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
74 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

ZIMMER BIOMET HOLDINGS, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $17.5B
Dividend Yield 0.26%
Revenue Growth 4.8% ↘
Op. Margin 15.0% ↘
ROIC 1.3% ↘
FCF / Share $2.05 ↗
Trailing P/E 88.3x
Price / Book 1.4x
FCF Yield 2.3%
Debt / Equity 0.50
info Valuation on last close. End-of-day price, Sep 23, 2026.

74-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.18B
↑ +4.8% —
Net Income Profit after all expenses
$198.30M
↑ +29.8% —
Operating Margin Operating profit as % of sales
15.0%
↓ -16.2% 64th
FCF / Share Free cash flow per share
$2.05
↑ +23.6% —
Long-Term Debt Long-term obligations
$6.28B
— -0.3% —

Health Breakdown

Profitability ↑
68
Returns ↑
55
Financial Health ↑
58
Cash Quality ↑
87

Dividend History

Dividend / share · sourced from SEC filings
$0.96 Latest / share
+0.0% YoY
+0.8% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 20 years · 74 quarters